European Heart Journal Advance Access originally published online on March 8, 2005
European Heart Journal 2005 26(7):723-727; doi:10.1093/eurheartj/ehi197
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent pericarditis: a multi-centre all-case analysis
1Cardiac Rehabilitation Institute, Sheba Medical Centre, Tel-Hashomer 52621, Israel
2Sackler school of Medicine, Tel Aviv University, Israel
3St Vincent Hospital, Worchester, MA, USA
4Department of Medicine Brera, Rheumatology, Niguarda Ca'Granda Hospital, Milan, Italy
5Service of Cardiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
6Service de Medicine Interne, Hopital de la Timone, Marseille, France
Received 12 April 2004; revised 8 January 2005; accepted 3 February 2005; online publish-ahead-of-print 8 March 2005.
* Corresponding author. Tel: 972 58 547138; fax: 972 3 5303079. E-mail address: adlery{at}sheba.health.gov.il
See page 631 for the editorial comment on this article (doi:10.1093/eurheartj/ehi045)
Aims Effective prevention of recurrent pericarditis remains an important yet elusive goal. Corticosteroid therapy often needs to be continued for a prolonged period and causes severe side effects. We performed a multi-centre all-case analysis to investigate the efficacy of colchicine in preventing subsequent relapses of pericarditis, and addressed the hypothesis that pretreatment with corticosteroids may attenuate the beneficial effect of colchicine.
Methods and results One hundred and forty published and unpublished cases of patients treated with colchicine after at least two relapses of pericarditis were aggregated from European centres. Of those, 119 were included in the study group. Only 18% of the patients had relapses under colchicine therapy, and 30% after its discontinuation. There were significantly more relapses among male patients after colchicine treatment (36 vs. 17%, P=0.046), and those with previous corticosteroid treatment (43 vs. 13%, P=0.02). Multivariate logistic regression analysis identified previous corticosteroid therapy (OR 6.68, 95% CI: 1.6527.02) and male gender (OR 4.20, 95% CI: 1.1615.21) as independent risk factors for recurrence following colchicine therapy.
Conclusion Treatment with colchicine is highly effective in preventing recurrent pericarditis, while pretreatment with corticosteroids exacerbates and extends the course of recurrent pericarditis.
Key Words: Pericarditis Corticosteroids Colchicine
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in EHJ:
- Recurrent pericarditis: mysterious or not so mysterious?
- Bernhard Maisch
EHJ 2005 26: 631-633.[Extract] [FREE Full Text]
This article has been cited by other articles:
![]() |
M. Imazio, A. Brucato, R. Trinchero, D. Spodick, and Y. Adler Colchicine for pericarditis: hype or hope? Eur. Heart J., March 1, 2009; 30(5): 532 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shabetai Corticosteroids for Recurrent Pericarditis: On the Road to Evidence-Based Medicine Circulation, August 5, 2008; 118(6): 612 - 613. [Full Text] [PDF] |
||||
![]() |
M. Imazio, A. Brucato, D. Cumetti, G. Brambilla, B. Demichelis, S. Ferro, S. Maestroni, E. Cecchi, R. Belli, G. Palmieri, et al. Corticosteroids for Recurrent Pericarditis: High Versus Low Doses: A Nonrandomized Observation Circulation, August 5, 2008; 118(6): 667 - 671. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H Spodick Risk prediction in pericarditis: who to keep in hospital? Heart, April 1, 2008; 94(4): 398 - 399. [Full Text] [PDF] |
||||
![]() |
M Imazio, E Cecchi, B Demichelis, A Chinaglia, S Ierna, D Demarie, A Ghisio, F Pomari, R Belli, and R Trinchero Myopericarditis versus viral or idiopathic acute pericarditis Heart, April 1, 2008; 94(4): 498 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Brucato, Y. Adler, D. H. Spodick, M. Imazio, E. Cecchi, D. Demarie, B. Demichelis, F. Pomari, M. Moratti, G. Gaschino, et al. Letter Regarding Article by Imazio et al, "Colchicine in Addition to Conventional Therapy for Acute Pericarditis" * Response Circulation, April 11, 2006; 113(14): e693 - e694. [Full Text] [PDF] |
||||
![]() |
M. Flather and J. Collinson First line treatment with colchicine reduced recurrent pericarditis Evid. Based Med., April 1, 2006; 11(2): 44 - 44. [Full Text] [PDF] |
||||
![]() |
W. C. Little and G. L. Freeman Pericardial Disease Circulation, March 28, 2006; 113(12): 1622 - 1632. [Full Text] [PDF] |
||||
![]() |
A. Brucato, G. Brambilla, Y. Adler, and D. H. Spodick Colchicine for recurrent acute pericarditis. Arch Intern Med, March 27, 2006; 166(6): 696 - 696. [Full Text] [PDF] |
||||
![]() |
A. Brucato, G. Brambilla, Y. Adler, and D. H. Spodick Recurrent pericarditis: therapy of refractory cases Eur. Heart J., December 1, 2005; 26(23): 2600 - 2601. [Full Text] [PDF] |
||||
![]() |
M. Imazio, M. Bobbio, E. Cecchi, D. Demarie, F. Pomari, M. Moratti, A. Ghisio, R. Belli, and R. Trinchero Colchicine as First-Choice Therapy for Recurrent Pericarditis: Results of the CORE (COlchicine for REcurrent pericarditis) Trial Arch Intern Med, September 26, 2005; 165(17): 1987 - 1991. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Brucato, Y Shinar, G Brambilla, L Robbiolo, G Ferrioli, M C Patrosso, D Zanni, S Penco, E Boiani, A Ghirardello, et al. Idiopathic recurrent acute pericarditis: familial Mediterranean fever mutations and disease evolution in a large cohort of Caucasian patients Lupus, September 1, 2005; 14(9): 670 - 674. [Abstract] [PDF] |
||||





